Date published: 2025-10-10

1-800-457-3801

SCBT Portrait Logo
Seach Input

ATP1B3 Activators

ATP1B3, also known as the beta-3 subunit of the Na+/K+-ATPase pump, plays a fundamental role in maintaining the electrochemical gradients of sodium and potassium ions across the plasma membrane. This gradient is essential for various cellular processes, including cell volume regulation, and the transport of nutrients and neurotransmitters. The expression of ATP1B3 is a tightly regulated process within cells, and understanding the mechanisms behind its upregulation can provide insights into cellular adaptations to various physiological stimuli. Certain compounds are known to induce the expression of genes like ATP1B3 by interacting with specific cellular pathways or regulatory elements within the gene's promoter region.

Compounds such as retinoic acid and forskolin are examples of molecules that can potentially induce the expression of ATP1B3. Retinoic acid, a metabolite of vitamin A, is known for its influential role in cell growth and differentiation. It can potentially upregulate ATP1B3 by binding to retinoic acid receptors, which then interact with DNA at specific response elements to activate transcription. Forskolin, a plant-derived compound, is known for increasing intracellular cAMP, which in turn activates protein kinase A (PKA). Activation of PKA can lead to enhanced transcription of targeted genes, including ATP1B3. This transcriptional activation occurs through the phosphorylation of transcription factors and alteration of chromatin structure, thereby increasing gene expression. Other compounds such as vitamin D3, estrogen, and certain inhibitors like sunitinib or PD 173074, also demonstrate the capability to potentially induce ATP1B3 expression through their respective signaling pathways. These pathways converge on the transcriptional machinery of the cell, ultimately leading to increased production of the ATP1B3 protein, which is pivotal for the cell's ionic balance and overall function.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

Retinoic acid may upregulate ATP1B3 through the activation of nuclear retinoic acid receptors, leading to alterations in DNA transcription processes and initiating the synthesis of ATP1B3 mRNA.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Forskolin may raise intracellular cAMP levels, which in turn could activate protein kinase A (PKA) and lead to an increase in the transcriptional activity of genes including ATP1B3.

L-3,3′,5-Triiodothyronine, free acid

6893-02-3sc-204035
sc-204035A
sc-204035B
10 mg
100 mg
250 mg
$40.00
$75.00
$150.00
(1)

T3 could stimulate the transcription of ATP1B3 by binding to thyroid hormone response elements in the gene's promoter region, thereby initiating the production of the ATP1B3 protein.

Dexamethasone

50-02-2sc-29059
sc-29059B
sc-29059A
100 mg
1 g
5 g
$76.00
$82.00
$367.00
36
(1)

Dexamethasone may stimulate the expression of ATP1B3 by interacting with glucocorticoid response elements in the gene's promoter, leading to enhanced transcription and subsequent translation.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium may upregulate ATP1B3 expression via the inhibition of glycogen synthase kinase-3, which could lead to increased transcriptional activity of genes involved in ionic transport.

β-Estradiol

50-28-2sc-204431
sc-204431A
500 mg
5 g
$62.00
$178.00
8
(1)

β-Estradiol has the potential to stimulate ATP1B3 gene expression by estrogen receptor-mediated interaction with estrogen response elements in the gene's promoter region.

Sunitinib, Free Base

557795-19-4sc-396319
sc-396319A
500 mg
5 g
$150.00
$920.00
5
(0)

Sunitinib, a VEGF receptor inhibitor, could upregulate ATP1B3 by attenuating VEGF-mediated signaling pathways, possibly leading to a compensatory increase in ATP1B3 expression.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$46.00
$140.00
$680.00
16
(1)

PD173074, a selective FGF receptor inhibitor, may lead to an increase in ATP1B3 expression as a homeostatic response to disrupted FGF-mediated growth and differentiation pathways.

Hydrocortisone

50-23-7sc-300810
5 g
$100.00
6
(1)

Hydrocortisone could stimulate ATP1B3 expression by binding to the glucocorticoid receptor, which may interact with glucocorticoid response elements upstream of the ATP1B3 gene.

Cholecalciferol

67-97-0sc-205630
sc-205630A
sc-205630B
1 g
5 g
10 g
$70.00
$160.00
$290.00
2
(1)

Cholecalciferol may induce ATP1B3 expression through its active metabolite, calcitriol, which can bind to vitamin D response elements in the gene's promoter, triggering an increase in gene transcription.